A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)

被引：0
|
作者：
Palumbo, Raffaella [1 ]
Bernardo, Antonio [1 ]
Strada, Maria Rosa [1 ]
Poggi, Guido [1 ]
Delmonte, Angelo [1 ]
Teragni, Cristina [1 ]
Frascaroli, Mara [1 ]
Bernardo, Giovanni [1 ]
机构：
[1] Fdn Maugeri, Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [31] First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
    van Meerten, E.
    Eskens, F. A. L. M.
    van Gameren, E. C.
    Doorn, L.
    van der Gaast, A.
    BRITISH JOURNAL OF CANCER, 2007, 96 (09) : 1348 - 1352
  • [32] Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)
    Lopez, Rafael
    Mendez Mendez, Carlos
    Jorge Fernandez, Monica
    Romero Reinoso, Carlos
    Quintero Aldana, Guillermo
    Salgado Fernandez, Mercedes
    De La Camara Gomez, Juan
    Reboredo Lopez, Margarita
    Ramos Vazquez, Manuel
    Candamio Folgar, Sonia
    ANTICANCER RESEARCH, 2013, 33 (02) : 717 - 723
  • [33] A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard. A., III
    Simons, Lisa
    Spigel, David R.
    Greco, E. Anthony
    Barton, John H.
    Shipley, Dianna
    Drosick, David
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2008, 8 (05) : 425 - 431
  • [34] Phase II Study of Bevacizumab in Combination with Docetaxel and Capecitabine for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer
    Musolino, A.
    Bisagni, G.
    De Matteis, A.
    Nuzzo, F.
    Ardizzoni, A.
    Crino, L.
    Gamucci, T.
    Passalacqua, R.
    Gnoni, R.
    Boni, C.
    CANCER RESEARCH, 2010, 70
  • [35] VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN
    Ameri, A.
    Shahrad, B.
    Madani, H.
    Fazlalizadeh, A.
    Mousavizadeh, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
  • [36] Phase II trial of first-line capecitabine plus cisplatin in patients with advanced/metastatic nasopharyngeal cancer (NPC)
    Chua, D.
    Ng, W.
    Yiu, H.
    Seetalarom, K.
    Kurnianda, J.
    Sze, W.
    Krishnan, G.
    Shotelersuk, K.
    Hong, R.
    Forster, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Capecitabine (X) in the first-line treatment of metastatic breast cancer (MBC).
    Harbeck, N.
    Kaufmann, M.
    Siedentopf, F.
    Dalivoust, P.
    Debled, M.
    Robert, N. J.
    O'Shaughnessy, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer
    Vrdoljak, E.
    Boban, M.
    Omrcen, T.
    Hrepic, D.
    Fridl-Vidas, V.
    Boskovic, L.
    NEOPLASMA, 2011, 58 (02) : 172 - 178
  • [39] A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer
    Hegg, R
    Costa, MA
    Perdicaris, M
    Delgado, GL
    Cabral, S
    Malzyner, A
    Caponero, R
    Yamagushi, N
    Novaes, N
    Anelli, A
    Correa, M
    Nader, L
    Andrade, C
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 16 (04) : 225 - 234
  • [40] PHASE II TRIAL OF FIRST-LINE CAPECITABINE PLUS OXALIPLATIN IN PATIENTS WITH METASTATIC NASOPHARYNGEAL CARCINOMA
    Chua, D.
    Ng, W. T.
    Ng, W. Y.
    Lui, C. Y.
    Li, V.
    Cheng, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 324 - 324
12345